CareDx, Inc. (CDNA) earnings

CDNA earnings moved a median of -0.41% by the close. Quarterly and annual CDNA reports and results, each read against the price at its own news timestamp. Back to the CDNA overview →

30 measured CDNA earnings events.

Where these CDNA earnings landedvs 30 measured CDNA earnings reactions
CDNA earningsMiddle 50% · -7.01% to +6.72%Zero: 0.00%Median: -0.41%Median -0.41%-10.00%0+10.00%
Middle 50% of CDNA earnings reactions-7.01% to +6.72%
Median reaction (to close)-0.41%
Measured reactions30
Point-in-time · zero look-ahead

Half of the 30 CDNA earnings events with a measured close landed between -7.01% and +6.72%; 47% closed up.

DateHeadlineEvent5-minTo close
CareDx Announces Second Quarter 2026 Financial ResultsPress release-0.89%+2.85%
Form 10-Q CareDx, Inc. For: Jun 30SEC filing · Form 10-Q-0.89%+2.85%
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026Press release+1.08%+10.82%
CareDx Announces First Quarter 2026 Financial ResultsPress release+0.90%-7.02%
Form 10-Q CareDx, Inc. For: Mar 31SEC filing · Form 10-Q+0.90%-7.02%
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026Press release+0.57%-0.57%
Form 10-K CareDx, Inc. For: Dec 31SEC filing · Form 10-K-1.68%+0.16%
CareDx Announces Third Quarter 2025 Financial ResultsPress release+2.79%+4.95%
Form 10-Q CareDx, Inc. For: Sep 30SEC filing · Form 10-Q+2.79%+4.95%
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025Press release+0.00%-0.59%
CareDx Announces Second Quarter 2025 Financial ResultsPress release-2.72%-0.41%
Form 10-Q CareDx, Inc. For: Jun 30SEC filing · Form 10-Q-2.72%-0.41%
CareDx to Report Second Quarter 2025 Financial ResultsPress release-0.53%-0.53%
CareDx Reports First Quarter 2025 ResultsPress release-5.56%-6.97%
Form 10-Q CareDx, Inc. For: Mar 31SEC filing · Form 10-Q-5.56%-6.97%
CareDx to Report First Quarter 2025 Financial ResultsPress release-1.64%-7.37%
Form 10-K CareDx, Inc. For: Dec 31SEC filing · Form 10-K+2.81%+7.32%
CareDx Reports Third Quarter 2024 Results and Raises Revenue GuidancePress release+5.30%+7.46%
Form 10-Q CareDx, Inc. For: Sep 30SEC filing · Form 10-Q+5.30%+7.46%
CareDx Reports Preliminary Financial Results for Third Quarter 2024Press release-7.08%-8.28%
CareDx Reports Second Quarter 2024 Results and Increases Revenue GuidancePress release-1.61%-9.31%
Form 10-Q CareDx, Inc. For: Jun 30SEC filing · Form 10-Q-1.61%-9.31%
CareDx to Report Second Quarter 2024 Financial ResultsPress release+1.61%+12.61%
CareDx Reports First Quarter 2024 ResultsPress release+9.78%+17.42%
Form 10-Q CareDx, Inc. For: Mar 31SEC filing · Form 10-Q+9.78%+17.42%
CareDx to Report First Quarter 2024 Financial ResultsPress release-1.00%-3.00%
Form 10-K CareDx, Inc. For: Dec 31SEC filing · Form 10-K+5.04%+9.35%
CareDx Reports Third Quarter 2023 ResultsPress release-1.06%-9.88%
Form 10-Q CareDx, Inc. For: Sep 30SEC filing · Form 10-Q-1.06%-9.88%
CareDx to Report Third Quarter 2023 Financial ResultsPress release+8.07%+3.95%
That’s how CDNA usually reacts to earnings — get an email when it moves on news →
Keep exploring

More CDNA: analyst actions → · SEC filings → · CDNA overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
Cosmos Health Inc. (COSM)4500.00%50%
ROCHE HOLDING LTD S/ADR (RHHBY)449+0.03%52%
Arvinas, Inc. (ARVN)442-0.26%42%
Jaguar Health, Inc. (JAGX)442-0.38%41%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.